DK2033629T3 - Fast farmaceutisk sammensætning omfattende valsartan - Google Patents

Fast farmaceutisk sammensætning omfattende valsartan

Info

Publication number: DK2033629T3
Authority: DK; Denmark
Prior art keywords: valsartan; pharmaceutical composition; solid pharmaceutical; solid; composition
Prior art date: 2004-12-24

Application number

DK08165631.6T

Other languages

English (en)

Inventor

Miha Vrbinc

Vovk Janika Slanc

Marija Rangus

Silvo Zupancic

Franci Bevec

Lidija Cernosa

Original Assignee

Krka

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-24

Filing date

2005-12-23

Publication date

2013-02-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35966966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2033629(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-24 Priority claimed from EP04030782A external-priority patent/EP1674080A1/en

2005-12-23 Application filed by Krka filed Critical Krka

2013-02-04 Application granted granted Critical

2013-02-04 Publication of DK2033629T3 publication Critical patent/DK2033629T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK08165631.6T 2004-12-24 2005-12-23 Fast farmaceutisk sammensætning omfattende valsartan DK2033629T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP04030782A EP1674080A1 (en)	2004-12-24	2004-12-24	Solid pharmaceutical composition comprising valsartan
EP05004433		2005-03-01
EP20050824409 EP1833464A1 (en)	2004-12-24	2005-12-23	Solid pharmaceutical composition comprising valsartan

Publications (1)

Publication Number	Publication Date
DK2033629T3 true DK2033629T3 (da)	2013-02-04

Family

ID=35966966

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08165631.6T DK2033629T3 (da)	2004-12-24	2005-12-23	Fast farmaceutisk sammensætning omfattende valsartan

Country Status (16)

Country	Link
US (1)	US20080102120A1 (da)
EP (2)	EP1833464A1 (da)
CN (1)	CN101087589B (da)
AU (1)	AU2005318365B2 (da)
CA (1)	CA2592091A1 (da)
DK (1)	DK2033629T3 (da)
EA (2)	EA012392B1 (da)
ES (1)	ES2397552T3 (da)
HR (1)	HRP20130033T1 (da)
ME (1)	ME01453B (da)
NO (1)	NO20073889L (da)
PL (1)	PL2033629T3 (da)
PT (1)	PT2033629E (da)
RS (1)	RS52607B (da)
SI (1)	SI2033629T1 (da)
WO (1)	WO2006066961A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20081364A1 (es) *	2006-09-04	2008-12-04	Novartis Ag	Composicion farmaceutica que comprende valsartan
EP1897537A1 (en) *	2006-09-04	2008-03-12	Novartis AG	Composition comprising an angiotensin II receptor antagonist
US20080152717A1 (en) *	2006-12-14	2008-06-26	Isp Investments, Inc.	Amorphous valsartan and the production thereof
TR200703568A1 (tr) *	2007-05-24	2008-07-21	Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�	Valsartan formülasyonları
GB0715628D0 (en) *	2007-08-10	2007-09-19	Generics Uk Ltd	Solid valsartan composition
WO2009113091A2 (en) *	2008-01-24	2009-09-17	Usv Limited	Pharmaceutical compositions comprising valsartan
WO2010104485A2 (en) *	2009-03-11	2010-09-16	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Valsartan formulations
SI2536396T1 (sl)	2010-02-16	2017-01-31	KRKA, tovarna zdravil, d.d.,Novo mesto	Postopek za pripravo oralnih trdnih odmernih oblik, ki obsegajo valsartan
CN102119912A (zh) *	2011-01-25	2011-07-13	南京白敬宇制药有限责任公司	一种非水溶性药物缓释制剂的制备方法
CN102204907A (zh) *	2011-03-31	2011-10-05	北京赛科药业有限责任公司	一种含缬沙坦的药物组合物及其制备方法
WO2013098578A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan hydrochlorothiazide
WO2013098576A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan
CN103599084B (zh) *	2013-11-22	2018-10-30	威海迪素制药有限公司	一种降压组合物
KR101545268B1 (ko)	2015-02-05	2015-08-20	보령제약 주식회사	정제 및 이의 제조방법
CN104887640B (zh) *	2015-06-30	2017-12-19	昆明医科大学	一种含有缬沙坦的固体药物组合物
US20210267908A1 (en) *	2020-03-02	2021-09-02	Mankind Pharma Ltd.	Pharmaceutical compositions of rivaroxaban
CN112098408B (zh) *	2020-09-14	2022-12-09	湖北亿纬动力有限公司	一种羧甲基纤维素钠溶解效果的检测方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122007000050I1 (de) *	1990-02-19	2007-11-08	Novartis Ag	Acylverbindungen
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
CN1636561A (zh)	1998-12-23	2005-07-13	诺瓦提斯公司	At－1受体拮抗剂在治疗与at－1受体增加有关的疾病中的应用
US6294192B1 (en) *	1999-02-26	2001-09-25	Lipocine, Inc.	Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6211217B1 (en) *	1999-03-16	2001-04-03	Novartis Ag	Method for reducing pericardial fibrosis and adhesion formation
US20030236236A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
BR0110079A (pt) *	2000-04-12	2002-12-31	Novartis Ag	Combinação de compostos orgânicos
US6499984B1 (en)	2000-05-22	2002-12-31	Warner-Lambert Company	Continuous production of pharmaceutical granulation
KR100659644B1 (ko)	2000-06-22	2006-12-21	노파르티스 아게	고형 발사르탄 약제학적 조성물
PE20020613A1 (es) *	2000-07-19	2002-08-07	Novartis Ag	Sales de (s)-n-(1-carboxi-2-metil-prop-1-il)-n-pentanoil-n-[2'-(1h-tetrazol-5-il)-bifenil-4-ilmetil]-amina como antagonista del receptor at1
US20030152622A1 (en) *	2001-10-25	2003-08-14	Jenny Louie-Helm	Formulation of an erodible, gastric retentive oral diuretic
JP4820056B2 (ja)	2002-01-17	2011-11-24	ノバルティスアーゲー	バルサルタンおよびｎｅｐ阻害剤を含む医薬組成物
WO2004054575A1 (en)	2002-12-18	2004-07-01	Novartis Ag	Combinations of valsartan with cox-2 inhibitors
CA2519490A1 (en)	2003-03-17	2004-09-30	Teva Pharmaceutical Industries Ltd	Polymorphis of valsartan
EP1556363A2 (en) *	2003-04-21	2005-07-27	Teva Pharmaceutical Industries Limited	Process for the preparation of valsartan and intermediates thereof
WO2004094392A1 (en) *	2003-04-21	2004-11-04	Teva Pharmaceutical Industries Ltd.	Process for the preparation of valsartan
US7915247B1 (en) *	2006-08-21	2011-03-29	Mutual Pharmaceutical Company, Inc.	Methods of use of fenofibric acid

2005
- 2005-12-23 EP EP20050824409 patent/EP1833464A1/en not_active Withdrawn
- 2005-12-23 ME MEP-2012-149A patent/ME01453B/me unknown
- 2005-12-23 AU AU2005318365A patent/AU2005318365B2/en not_active Ceased
- 2005-12-23 EA EA200701107A patent/EA012392B1/ru not_active IP Right Cessation
- 2005-12-23 EP EP08165631A patent/EP2033629B1/en not_active Revoked
- 2005-12-23 SI SI200531638T patent/SI2033629T1/sl unknown
- 2005-12-23 RS RS20120564A patent/RS52607B/en unknown
- 2005-12-23 CN CN2005800447851A patent/CN101087589B/zh not_active Expired - Fee Related
- 2005-12-23 WO PCT/EP2005/013963 patent/WO2006066961A1/en active Application Filing
- 2005-12-23 ES ES08165631T patent/ES2397552T3/es active Active
- 2005-12-23 US US11/794,039 patent/US20080102120A1/en not_active Abandoned
- 2005-12-23 PT PT81656316T patent/PT2033629E/pt unknown
- 2005-12-23 EA EA200900646A patent/EA015108B1/ru not_active IP Right Cessation
- 2005-12-23 DK DK08165631.6T patent/DK2033629T3/da active
- 2005-12-23 CA CA002592091A patent/CA2592091A1/en not_active Abandoned
- 2005-12-23 PL PL08165631T patent/PL2033629T3/pl unknown
2007
- 2007-07-24 NO NO20073889A patent/NO20073889L/no not_active Application Discontinuation
2013
- 2013-01-16 HR HRP20130033TT patent/HRP20130033T1/hr unknown

Also Published As

Publication number	Publication date
NO20073889L (no)	2007-09-24
SI2033629T1 (sl)	2013-01-31
AU2005318365B2 (en)	2011-02-03
EA200701107A1 (ru)	2008-04-28
EP2033629B1 (en)	2012-11-14
ES2397552T3 (es)	2013-03-07
AU2005318365A1 (en)	2006-06-29
WO2006066961A1 (en)	2006-06-29
PL2033629T3 (pl)	2013-04-30
EP1833464A1 (en)	2007-09-19
EA200900646A1 (ru)	2009-10-30
US20080102120A1 (en)	2008-05-01
HRP20130033T1 (hr)	2013-02-28
CN101087589A (zh)	2007-12-12
RS52607B (en)	2013-04-30
EA012392B1 (ru)	2009-10-30
CN101087589B (zh)	2013-01-30
EP2033629A1 (en)	2009-03-11
PT2033629E (pt)	2013-01-24
EA015108B1 (ru)	2011-06-30
CA2592091A1 (en)	2006-06-29
ME01453B (me)	2014-04-20

Publication	Publication Date	Title
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
RU2398586C3 (ru)	2017-10-04	Фармацевтическая композиция
DK1940467T3 (da)	2017-02-13	Lægemiddelsammensætning med langvarig frigivelse
NO20075628L (no)	2007-11-05	Farmasøytiske formuleringer
ITBO20050123A1 (it)	2005-06-06	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
DK1957073T3 (da)	2014-05-12	Lægemiddel
DK1725218T3 (da)	2014-09-01	Farmaceutisk sammensætning omfattende pimobendan
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
DK2033629T3 (da)	2013-02-04	Fast farmaceutisk sammensætning omfattende valsartan
EP1937255A4 (en)	2013-06-26	PHARMACEUTICAL COMPOSITION
EP1862184A4 (en)	2012-12-19	PHARMACEUTICAL COMPOSITION
ZA200705131B (en)	2008-06-25	Solid pharmaceutical composition comprising valsartan
BRPI0614413A2 (pt)	2016-11-22	composto, e, composição farmacêutica
BRPI0614412A2 (pt)	2016-11-22	composto, e, composição farmacêutica
DE602005017191D1 (de)	2009-11-26	Geruchsreduzierte waschstück-zusammensetzung
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
GB2411355B (en)	2006-02-22	Pharmaceutical composition
FR2871686B1 (fr)	2008-02-29	Composition anti-decoloration
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
ZA200701931B (en)	2008-10-29	Pharmaceutical composition
FR2868774B1 (fr)	2007-01-12	Composition explosive